| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/07/1994 | CA2153064A1 Plasticized bioerodible controlled delivery system |
| 07/07/1994 | CA2153063A1 Bioerodible controlled delivery system |
| 07/07/1994 | CA2151818A1 Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof |
| 07/07/1994 | CA2151491A1 Fluorocarbon emulsions |
| 07/07/1994 | CA2151386A1 Prevention and treatment of sepsis |
| 07/07/1994 | CA2129991A1 Improved peritoneal dialysis solutions with polypeptides |
| 07/06/1994 | EP0605203A2 Antiallergic composition for ophthalmic or nasal use |
| 07/06/1994 | EP0605174A1 Delayed, Sustained-release pharmaceutical preparation |
| 07/06/1994 | EP0605024A2 Use of purified surface modifiers to prevent particle aggregation during sterilization |
| 07/06/1994 | EP0604848A2 Quick-drying gel-type disinfectant for hands and fingers |
| 07/06/1994 | EP0604806A2 Composition containing phospholipids |
| 07/06/1994 | EP0604653A1 Complex of compound having chalcone skeleton |
| 07/06/1994 | EP0604624A1 Multimeric forms of human rhinovirus receptor protein |
| 07/06/1994 | EP0604570A1 Compositions containing quinolone antibiotics and sulfonate of polystyrol |
| 07/06/1994 | EP0572624A4 Lubricous polymer network |
| 07/06/1994 | EP0375785B1 Lipid composition having enough safety and strong surface activity |
| 07/06/1994 | CN1088986A Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 07/06/1994 | CN1088936A Peg-interferon conjugates |
| 07/06/1994 | CN1088838A Preparation of aseptic carrier for Chinese medicine granules and its granules |
| 07/06/1994 | CN1088778A Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| 07/06/1994 | CN1025283C Process for preparing beads used in production of controlled-release products |
| 07/05/1994 | US5326856 Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding |
| 07/05/1994 | US5326778 Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy |
| 07/05/1994 | US5326761 Suspension; sustained release |
| 07/05/1994 | US5326753 Freeze-dried composition containing a 2-dimethylamino etoposide derivative |
| 07/05/1994 | US5326586 Coating of drug forms |
| 07/05/1994 | US5326571 Dosage forms comprising polymers comprising different molecular weights |
| 07/05/1994 | US5326567 Photostability, silver ions complexed in polyether, stabilizing halides |
| 07/05/1994 | US5326566 Use of dibutyl adipate and isopropyl myristate in topical and transdermal products |
| 07/05/1994 | US5326559 Treatment of accelerated atheosclerosis with interleukin-2 receptor targeted molecules |
| 07/05/1994 | CA1330531C Method of treating tinea pedis and related dermatophytic infections |
| 06/29/1994 | EP0604143A2 Rapamycin loaded formed blood elements to induce immunosuppression |
| 06/29/1994 | EP0603992A1 Oral administration of immunologically active biomolecules and other therapeutic proteins |
| 06/29/1994 | EP0603405A1 Composition for treating acne vulgaris |
| 06/29/1994 | EP0603303A1 Antimicrobial compositions containing propylene carbonate and/or ethylene carbonate as the carrier solvent |
| 06/29/1994 | EP0603194A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 06/29/1994 | EP0565618A4 Stabilization of proteins by cationic biopolymers |
| 06/29/1994 | EP0554343B1 Dna gel stabilized thermal water liposomes |
| 06/29/1994 | EP0470183B1 Fibroblast growth factor conjugates |
| 06/29/1994 | EP0444118B1 Pyruvate-kinase-isoenzyme-type-m2 (tumour m2-pk) specific antibodies, process for producing them and use |
| 06/29/1994 | CN1088457A Transdermal therapeutic system for the administration of physostigmine to the skin and process for the production thereof |
| 06/29/1994 | CN1088456A Stable microbubble suspensions as enhancement agents for ultrasound echography |
| 06/29/1994 | CN1025150C Pharmaceutical preparations with extended release |
| 06/28/1994 | US5324844 Active carbonates of polyalkylene oxides for modification of polypeptides |
| 06/28/1994 | US5324828 1-amino-1-deoxyoligosaccharides and derivatives thereof |
| 06/28/1994 | US5324821 Method of preparing a lipoprotein modified by incorporation of a lipophilic active substance |
| 06/28/1994 | US5324775 Bound to a synthetic non-immunogenic hydrophilic polyethylene glycol polymer; can be injected into humans to augment soft tissue |
| 06/28/1994 | US5324751 Fast dissolving; free-flowing; polymorphs; open centered acicular microcrystals |
| 06/28/1994 | US5324750 Coagulation of powdered catalyst; separation |
| 06/28/1994 | US5324749 Pharmaceutical aqueous solution of 4-[2-(benzene-sulphonylamino)-ethyl]-phenoxyacetic acid |
| 06/28/1994 | US5324718 Complexing with natural and synthetic polymers; high speed drug release |
| 06/28/1994 | US5324523 Controlled release pharmaceutical preparation and process for preparing same |
| 06/28/1994 | US5324519 Biodegradable polymer composition |
| 06/28/1994 | US5324351 For coating drug and food products |
| 06/28/1994 | CA1330422C Reduction of neurotoxic effects of cytotoxic agents |
| 06/28/1994 | CA1330417C Organic compounds |
| 06/25/1994 | CA2112160A1 Compositions of l-dopa esters |
| 06/24/1994 | CA2110853A1 Delayed, sustained release pharmaceutical preparation |
| 06/23/1994 | WO1994013817A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 06/23/1994 | WO1994013724A1 Use of cationic polyurethanes and polycarbamides as auxiliary substances in cosmetic and pharmaceutical compositions |
| 06/23/1994 | WO1994013697A1 Treatment of septic shock with conjugated biologically active peptides |
| 06/23/1994 | WO1994013682A1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
| 06/23/1994 | WO1994013329A1 Process for preparing a virus-safe biological composition |
| 06/23/1994 | WO1994013327A1 Immunoreactive reagents employing dihydrofolate reductase |
| 06/23/1994 | WO1994013325A2 Peptide linkers for improved oligonucleotide delivery |
| 06/23/1994 | WO1994013324A1 Lipid prodrugs for oral administration |
| 06/23/1994 | WO1994013323A1 Method of inhibiting the clearance of liposomes from the circulation |
| 06/23/1994 | WO1994013322A1 Improved synthesis of polymer bio-active conjugates |
| 06/23/1994 | WO1994013317A1 Sustained-release preparation |
| 06/23/1994 | WO1994013316A1 Potent and specific chemically-conjugated immunotoxins |
| 06/23/1994 | WO1994013311A1 Glycolipid enzyme-polymer conjugates |
| 06/23/1994 | WO1994013281A1 Anti-inflammatory and analgesic gel preparation |
| 06/23/1994 | WO1994013279A1 Effervescent pharmaceutical composition containing ibuprofen and method for preparing same |
| 06/23/1994 | WO1994013274A1 Stabilized catecholamine solutions |
| 06/23/1994 | WO1994013263A1 Stabilized medicinal aerosol solution formulations |
| 06/23/1994 | WO1994013262A1 Stabilized medicinal aerosol solution formulations |
| 06/23/1994 | WO1994013235A1 Skin adhesive hydrogel, its preparation and uses |
| 06/23/1994 | WO1994013143A1 Stabilized lanthionine bacteriocin compositions |
| 06/23/1994 | WO1994008551A3 Pharmaceutical compositions and methods for treating cold symptoms |
| 06/23/1994 | DE4340609A1 Compsn for slow evapn of terpenoid, e.g. limonene - contg antioxidant and polymer carrier, used e.g. as fragrance, disinfectant, insecticide and deodorant |
| 06/23/1994 | CA2151614A1 Immunoreactive reagents employing dihydrofolate reductase |
| 06/23/1994 | CA2151046A1 Treatment of septic shock with conjugated biologically active peptides |
| 06/23/1994 | CA2150956A1 Glycolipid enzyme-polymer conjugates |
| 06/23/1994 | CA2150033A1 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer |
| 06/23/1994 | CA2149754A1 Lipid prodrugs for oral administration |
| 06/23/1994 | CA2148805A1 Use of cationic polyurethanes and polycarbamides as auxilliary substances in cosmetic and pharmaceutical compositions |
| 06/23/1994 | CA2129744A1 Skin adhesive hydrogel, its preparation and uses |
| 06/23/1994 | CA2110939A1 An innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
| 06/22/1994 | EP0603159A2 Human growth hormone formulation |
| 06/22/1994 | EP0602702A1 The use of tyloxapol as a nanoparticle stabilizer and dispersant |
| 06/22/1994 | EP0602586A2 Stable pharmaceutical composition of fumagillol derivatives |
| 06/22/1994 | EP0602585A2 Dialysis solution for a peritoneal dialysis |
| 06/22/1994 | EP0602290A1 Cellular drug anchors |
| 06/22/1994 | EP0602280A1 Stabilized caloric nutritive solution and Multiple chambers device for the parenteral nutrition of man |
| 06/22/1994 | EP0602144A1 Dna sequences encoding gelonin polypeptide |
| 06/22/1994 | EP0602112A1 High content ibuprofen agglomerates and process to prepare them |
| 06/22/1994 | EP0513072B1 Improved cyclodextrin based erythropoietin formulation |
| 06/22/1994 | EP0486525B1 Stabilized protein or peptide conjugates |
| 06/22/1994 | EP0437479B1 Method of making liposomes with improved stability during drying |
| 06/22/1994 | CN1088210A Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |